FDA res­ur­rects pro­pos­al to gauge qual­i­ty met­rics in phar­ma man­u­fac­tur­ing

The FDA is once again re­turn­ing to its hot­ly-con­test­ed qual­i­ty met­rics pro­gram for phar­ma man­u­fac­tur­ers, even as com­pa­nies have ex­pressed ma­jor reser­va­tions.

The agency’s fo­cus …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER